Biogen Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.48B | 2.28B | 2.45B | 2.65B | 2.43B | 2.45B | 2.47B | 2.46B |
| Cost of Goods Sold | 661.0M | 496.3M | 876.6M | 946.2M | 577.9M | 583.5M | 638.7M | 955.8M |
| Gross Profit | 1.82B | 1.78B | 1.58B | 1.70B | 1.85B | 1.87B | 1.83B | 1.51B |
| R&D Expenses | 573.0M | 509.3M | 369.6M | 529.9M | 545.9M | 683.5M | 673.0M | 592.3M |
| Operating Expenses | 1.42B | 1.84B | 964.4M | 1.11B | 1.12B | 1.36B | 1.25B | 1.14B |
| Operating Income | 397.4M | -57.0M | 613.8M | 588.1M | 732.6M | 509.0M | 577.2M | 366.5M |
| Other Income / Gains | -19.7M | -154.0M | -56.5M | 155.9M | -421.4M | -217.5M | -126.2M | 332.2M |
| Net Income | 319.5M | -48.4M | 466.5M | 634.8M | 240.5M | 266.7M | 388.5M | 583.6M |
| EPS (Diluted) | 2.17 | -0.33 | 3.18 | 4.35 | 1.65 | 1.83 | 2.67 | 4.01 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.733 | 0.782 | 0.643 | 0.642 | 0.762 | 0.762 | 0.741 | 0.612 |
| General And Administrative Expenses | 0 | 683.0M | 0 | 0 | 0 | 611.9M | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 66.8M | 0 | 0 |
| Selling General And Administrative Expenses | 607.3M | 683.0M | 594.8M | 581.3M | 574.6M | 678.7M | 576.9M | 550.3M |
| Other Expenses | 239.1M | 647.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 2.08B | 2.34B | 1.84B | 2.06B | 1.70B | 1.95B | 1.89B | 2.10B |
| Interest Income | 37.9M | 37.2M | 31.6M | 32.3M | 23.9M | 18.5M | 11.6M | 20.1M |
| Interest Expense | 67.6M | 67.5M | 67.4M | 72.6M | 60.0M | 60.0M | 59.8M | 61.3M |
| Depreciation And Amortization | 136.5M | 355.7M | 202.2M | 194.3M | 183.2M | 184.0M | 182.8M | 158.9M |
| Ebitda | 553.6M | 298.7M | 826.9M | 1.11B | 865.1M | 691.7M | 714.4M | 968.4M |
| Ebitdaratio | 0.223 | 0.131 | 0.337 | 0.42 | 0.356 | 0.282 | 0.29 | 0.393 |
| Operating Income Ratio | 0.16 | -0.025 | 0.25 | 0.222 | 0.301 | 0.207 | 0.234 | 0.149 |
| Income Before Tax | 377.7M | -211.0M | 557.3M | 744.0M | 311.2M | 291.5M | 451.0M | 698.7M |
| Income Before Tax Ratio | 0.152 | -0.093 | 0.227 | 0.281 | 0.128 | 0.119 | 0.183 | 0.283 |
| Income Tax Expense | 58.2M | -162.6M | 90.8M | 109.2M | 70.7M | 24.8M | 62.5M | 115.1M |
| Net Income Ratio | 0.129 | -0.021 | 0.19 | 0.24 | 0.099 | 0.109 | 0.158 | 0.237 |
| Epsdiluted | 2.15 | -0.33 | 3.17 | 4.35 | 1.64 | 1.83 | 2.66 | 4.00 |
| Weighted Average Shs Out | 147.2M | 146.7M | 146.6M | 145.9M | 145.9M | 145.7M | 145.7M | 145.6M |
| Weighted Average Shs Out Dil | 148.4M | 146.7M | 147.1M | 145.9M | 145.9M | 146.1M | 145.9M | 145.9M |